I anticipate that the share price before the release will exceed the value seen from the Scripps results given the heightened significance of the outcome this time around. The data from bit225-011 (ART for several years with no or reduced immune response) is IMO the most awaited. It's already established that bit225 triggers an immune response to HIV; this data is set to validate that, and ideally, also demonstrate a sustained immune response in at risk populations, or maybe even complete eradication. Should that be accomplished, the potential impact on the share price would be mind blowing.
I anticipate that the share price before the release will exceed...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.002(3.70%) |
Mkt cap ! $50.52M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.2¢ | $51.10K | 945.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4281 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 625000 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.002 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.2¢ | 5.6¢ | 5.2¢ | 183067 | ||
| Last updated 15.53pm 06/05/2024 ? | |||||
| BIT (ASX) Chart |